연구성과로 돌아가기
JCR 2022 저널 목록 (1502 / 2070)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Research in Toxicology | ELSEVIER | 2666-027X | 2666-027X | ESCI | TOXICOLOGY | 215 | 3.3 | N/A | 100.0 | N/A | N/A | 3.3 | N/A | 3.2 | 0.9 | 0.92 | 27/101 | Q2 | 73.76 | 0.000 | 0.067 | 0.628 | Q3 | 35 | 94.3% | 1.6 | 9.3 | 33 | 100.0% | 2025-04-21 10:39:26 | 바로가기 |
| Current Respiratory Medicine Reviews | BENTHAM SCIENCE PUBL LTD | 1573-398X | 1875-6387 | ESCI | RESPIRATORY SYSTEM | 120 | 0.2 | N/A | 100.0 | N/A | N/A | 0.2 | N/A | 0.2 | 0.1 | 0.05 | 97/101 | Q4 | 4.46 | 0.000 | 0.010 | 0.030 | Q4 | 39 | 56.4% | 9.1 | 7.7 | 22 | 0.0% | 2025-04-21 10:35:01 | 바로가기 |
| Current Reviews in Clinical and Experimental Pharmacology | BENTHAM SCIENCE PUBL LTD | 2772-4328 | 2772-4336 | ESCI | PHARMACOLOGY & PHARMACY | 84 | 1.1 | N/A | 100.0 | N/A | N/A | 1.1 | N/A | 1.0 | 1.6 | 0.40 | 274/366 | Q3 | 25.27 | 0.000 | 0.021 | 0.250 | Q2 | 23 | 39.1% | N/A | 8.4 | 9 | 3.0% | 2025-04-21 10:24:03 | 바로가기 |
| Current Rheumatology Reviews | BENTHAM SCIENCE PUBL LTD | 1573-3971 | 1875-6360 | ESCI | RHEUMATOLOGY | 701 | 1.5 | N/A | 100.0 | N/A | N/A | 2.0 | N/A | 1.5 | 0.5 | 0.36 | 40/54 | Q3 | 26.85 | 0.001 | 0.177 | 0.428 | Q3 | 48 | 62.5% | 4.9 | 10.7 | 30 | 0.0% | 2025-04-21 10:35:12 | 바로가기 |
| Current Sexual Health Reports | SPRINGERNATURE | 1548-3584 | 1548-3592 | ESCI | UROLOGY & NEPHROLOGY | 633 | 2.0 | N/A | 100.0 | N/A | N/A | N/A | N/A | 1.9 | 0.1 | 0.44 | 83/125 | Q3 | 34.00 | 0.001 | 0.278 | N/A | N/A | 29 | 48.3% | 4.9 | 6.3 | 14 | 13.4% | 2025-04-21 10:40:16 | 바로가기 |
| Current Sleep Medicine Reports | SPRINGERNATURE | N/A | 2198-6401 | ESCI | CLINICAL NEUROLOGY | 479 | 1.8 | N/A | 100.0 | N/A | N/A | N/A | N/A | 1.7 | 0.3 | 0.37 | 219/269 | Q4 | 18.77 | 0.001 | 0.198 | N/A | N/A | 20 | 70.0% | 5.1 | 7.0 | 14 | 18.0% | 2025-04-21 09:39:23 | 바로가기 |
| Current Stem Cell Reports | SPRINGER HEIDELBERG | N/A | 2198-7866 | ESCI | CELL & TISSUE ENGINEERING | 368 | 1.4 | N/A | 100.0 | N/A | N/A | 1.6 | N/A | 1.4 | 0.7 | 0.29 | 29/31 | Q4 | 8.06 | 0.000 | 0.098 | 0.395 | Q2 | 20 | 100.0% | 5.4 | 5.9 | 20 | 24.1% | 2025-04-21 09:36:35 | 바로가기 |
| Current Surgery Reports | SPRINGER | 2167-4817 | 2167-4817 | ESCI | SURGERY | 190 | 0.6 | N/A | 100.0 | N/A | N/A | 0.7 | N/A | 0.6 | 0.1 | 0.27 | 227/286 | Q4 | 20.80 | 0.000 | 0.054 | 0.205 | Q2 | 35 | 91.4% | 5.9 | 5.6 | 32 | 3.2% | 2025-04-21 10:38:16 | 바로가기 |
| CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | ELSEVIER SCIENCE INC | 0011-393X | 1879-0313 | ESCI | MEDICINE, RESEARCH & EXPERIMENTAL | 943 | 1.9 | N/A | 100.0 | N/A | N/A | 2.0 | N/A | 1.9 | 0.3 | 0.36 | 145/190 | Q4 | 23.95 | 0.001 | 0.113 | 0.435 | Q2 | 27 | 74.1% | 11.5 | 6.5 | 20 | 98.0% | 2025-04-21 10:16:05 | 바로가기 |
| Current Traditional Medicine | BENTHAM SCIENCE PUBL LTD | 2215-0838 | 2215-0846 | ESCI | INTEGRATIVE & COMPLEMENTARY MEDICINE | 130 | 0.6 | N/A | 100.0 | N/A | N/A | 0.6 | N/A | 0.6 | 0.3 | 0.13 | 39/42 | Q4 | 8.33 | 0.000 | 0.023 | 0.073 | Q4 | 33 | 18.2% | 2.8 | 8.7 | 6 | 0.0% | 2025-04-21 10:05:39 | 바로가기 |
| Current Transplantation Reports | SPRINGERNATURE | N/A | 2196-3029 | ESCI | SURGERY | 516 | 2.1 | N/A | 100.0 | N/A | N/A | N/A | N/A | 2.0 | 0.9 | 0.61 | 146/286 | Q3 | 49.13 | 0.001 | 0.236 | N/A | N/A | 35 | 80.0% | 3.9 | 4.3 | 28 | 24.2% | 2025-04-21 10:38:13 | 바로가기 |
| Current Transplantation Reports | SPRINGERNATURE | N/A | 2196-3029 | ESCI | TRANSPLANTATION | 516 | 2.1 | N/A | 100.0 | N/A | N/A | N/A | N/A | 2.0 | 0.9 | 0.61 | 17/32 | Q3 | 48.44 | 0.001 | 0.236 | N/A | N/A | 35 | 80.0% | 3.9 | 4.3 | 28 | 24.2% | 2025-04-21 10:39:39 | 바로가기 |
| Current Trauma Reports | SPRINGER | 2198-6096 | 2198-6096 | ESCI | CRITICAL CARE MEDICINE | 168 | 0.7 | N/A | 100.0 | N/A | N/A | 0.7 | N/A | 0.7 | 0.4 | 0.08 | 48/53 | Q4 | 10.38 | 0.000 | 0.062 | 0.215 | Q3 | 25 | 68.0% | 5.1 | 5.9 | 17 | 7.8% | 2025-04-21 09:43:43 | 바로가기 |
| Current Treatment Options in Allergy | SPRINGERNATURE | N/A | 2196-3053 | ESCI | ALLERGY | 205 | 1.1 | N/A | 100.0 | N/A | N/A | N/A | N/A | 1.1 | 0.4 | 0.22 | 29/38 | Q4 | 25.00 | 0.000 | 0.068 | N/A | N/A | 28 | 85.7% | 3.8 | 6.1 | 24 | 8.1% | 2025-04-21 09:30:36 | 바로가기 |
| Current Treatment Options in Cardiovascular Medicine | SPRINGERNATURE | 1092-8464 | 1534-3189 | ESCI | CARDIAC & CARDIOVASCULAR SYSTEMS | 1,092 | 0.8 | N/A | 100.0 | N/A | N/A | N/A | N/A | 0.8 | 0.2 | 0.20 | 174/215 | Q4 | 19.30 | 0.002 | 0.428 | N/A | N/A | 16 | 81.2% | 5.1 | 5.8 | 13 | 5.4% | 2025-04-21 09:36:03 | 바로가기 |
페이지 이동: